Demonstration of autoimmunity in the tight skin-2 mouse: A model for scleroderma

Journal of Immunology

Volumn 175, Issue 4, 2005, Pages 2418-2426

  Gentiletti, Julieta ^a   McCloskey, Laura J ^a   Artlett, Carol M ^a   Peters, Josephine ^b   Jimenez, Sergio A ^a   Christner, Paul J ^a,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MRC MAMMALIAN GENETICS UNIT   (United Kingdom)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA; RIBONUCLEOPROTEIN ANTIBODY; RNA POLYMERASE II; SCL 70 ANTIBODY; SM ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; CENTROMERE; CONTROLLED STUDY; CRITHIDIA; CRITHIDIA LUCILIAE; DERMIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEP 2 CELL; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE; MONONUCLEAR CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SCLERODERMA; SKIN;

EID: 23444460264     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.4.2418     Document Type: Article

References (50)

1. Chung, L., and P. J. Utz. 2004. Antibodies in scleroderma: direct pathogenicity and phenotypic associations. Curr. Rheumatol. Rep. 6: 156-163.
2. Derk, C., and S. Jimenez. 2003. Systemic sclerosis: current views of its pathogenesis. Autoimmun. Rev. 2: 181-191.
3. Cepeda, E. J., and J. D. Reveille. 2004. Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Curr. Opin. Rheumatol. 16: 723-732.
4. Okano, Y. 1996. Scleroderma: antinuclear antibody in systemic sclerosis (scleroderma). Rheum. Dis. Clin. North Am. 22: 709-735.
5. Furuta, K., B. Hildebrandt, S. Matsuoka, K. Kiyosawa, G. Reimer, C. Luderschmidt, E. K. Chan, and E. M. Tan. 1998. Immunological characterization of heterochromatin protein p25β autoantibodies and relationship with centromere autoantibodies and pulmonary fibrosis in systemic scleroderma. J. Mol. Med. 76: 54-60.
6. Chan, H. L., Y. S. Lee, H. S. Hong, and T. T. Kuo. 1994. Anticentromere antibodies (ACA): clinical distribution and disease specificity. Clin. Exp. Dermatol. 19: 298-302.
7. Ho, K., and J. Reveille. 2003. The clinical relevance of autoantibodies in scleroderma. Review. Arthritis Res. Ther. 5: 80-93.
8. Maul, G. G., S. A. Jimenez, E. Riggs, and D. Ziemnicka-Kotula. 1989. Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis. Proc. Natl. Acad. Sci. USA 86: 8492-846.
9. Hu, P. Q., N. Fertig, T. A. Medsger, Jr., and T. M. Wright. 2004. Molecular recognition patterns of serum anti-DNA topoisomerase I antibody in systemic sclerosis. J. Immunol. 173: 2834-2841.
10. Okano, Y., V. Steen, and T. Medger. 1993. Autoantibody reactive with RNA-polymerase III in systemic sclerosis. Ann. Intern. Med. 119: 1005-1013.
11. Hachulla, E., and S. Dubucquoi. 2004. Nuclear auto-antibodies: a useful tool for the diagnosis, the classification and the prognosis of systemic sclerosis. Rev. Med. Intern. 25: 442-447.
12. Reveille, J. D., and D. H. Solomon. 2003. The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl70 and nucleolar antibodies. Arthritis Rheum. 49: 399-412.
13. Reveille, J. D. 2004. Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus. 13: 290-297.
14. Hahn, B. H. 1998. Autoantibodies to DNA. N. Engl. J. Med. 338: 1359-1368.
15. Wada, Y., S. Ito, M. Ueno, M. Nakano, M. Arakawa, and F. Gejyo. 2004. Renal outcome and predictors of clinical renal involvement in patients with silent lupus nephritis. Nephron Clin. Pract. 98: c105-c111.
16. Cortes-Hernandez, J., J. Ordi-Ros, M. Labrador, S. Bujan, E. Balada, A. Segarra, and M. Vilardell-Tarres. 2004. Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am. J. Med. 116: 165-173.
17. Rekvig, O. P., M. Kalaaji, and H. Nossent. 2004. Anti-DNA antibody subpopulations and lupus nephritis. Autoimmun. Rev. 3: 1-6.
18. Haugbro, K., J. C. Nossent, T. Winkler, Y. Figenschau, and O. P. Rekvig. 2004. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Ann. Rheum. Dis. 63: 386-394.
19. Bagavant, H., U. S. Deshmukh, F. Gaskin, and S. M. Fu. 2004. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage. Scand. J. Immunol. 60: 52-63.
20. Hoffman, I. E., I. Peene, L. Meheus, T. W. Huizinga, L. Cebecauer, D. Isenberg, K. De Bosschere, F. Hulstaert, E. M. Veys, and F. De Keyser. 2004. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann. Rheum. Dis. 63: 1155-1158.
21. Cabra, A. R., and D. Alarcon-Segovia. 1997. Autoantibodies in systemic lupus erythematosus. Curr. Opin. Rheumatol. 9: 387-392.
22. Harris, M., and A. Rosen. 2003. Autoimmunity on scleroderma: the origin, pathogenic role and clinical significance of autoantibodies. Curr. Opin. Rheumatol. 15: 778-784.
23. Weiner, E. S., W. C. Earnshaw, J. L. Senecal, B. Bordwell, P. Johnson, and N. F. Rothfield. 1988. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I: a study of 355 patients. Arthritis Rheum. 31: 378-385.
24. Steen, V. D., D. L. Powell, and T. A. Medsger. 1988. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum. 31: 196-203.
25. Steen, V. 2004. The heart in systemic sclerosis. Curr. Rheumatol. Rep. 6: 137-140.
26. Hesselstrand, R., A. Scheja, and A. Shen. 2003. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology 42: 534-540.
27. Phan, T. G., A. Cass, A. Gillin, P. Trew, N. Fertig, and A. Sturgess. 1999. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis sine scleroderma. J. Rheumatol. 26: 2489-2492.
28. Rothfield, N. F. 1992. Autoantibodies in scleroderma. Rheum. Dis. Clin. North Am. 18: 483-498.
29. Catoggio, L. J., R. M. Bernstein, C. M. Black, G. R. Hughes, and P. J. Maddison. 1983. Serological markers in progressive systemic sclerosis: clinical correlations. Am. Rheum. Dis. 42: 23-27.
30. Bernstein, R. M. 1991. Antibodies to intracellular antigens in systemic autoimmune disease. Biochem. Soc. Trans. 19: 159-164.
31. Black, C. M., K. I. Welsh, P. J. Maddison, M. I. Jayson, and R. M. Bernstein. 1984. HLA antigens, autoantibodies and clinical subsets in scleroderma. Br. J. Rheumatol. 23: 267-271.
32. Hu, P. Q., N. Fertig, T. A. Medsger, Jr., and T. M. Wright. 2003. Correlation of serum anti DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum. 48: 1363-1373.
33. Peters, J., and S. T. Ball. 1986. Tight skin 2 (Tsk2/+). Mouse News Lett. 74: 91.
34. Christner, P., J. Peters, D. Hawkins, L. D. Siracusa, and S. A. Jimenez. 1995. The tight skin 2 mouse: an animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltration. Arthritis Rheum. 38: 1791-1798.
35. Siracusa, L., R. McGrath, Q. Ma, J. J. Moskow, J. Manne, P. J. Christner, A. M. Buchberg, and S. A. Jimenez. 1996. A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res. 6: 300-313.
36. Bocchieri, M. H., P. D. Henriksen, K. N. Kasturi, T. Muryoi, C. A. Bona, and S. A. Jimenez. 1991. Evidence for autoimmunity in the tight skin mouse model of systemic sclerosis. Arthritis Rheum. 34: 599-605.
37. Kasturi, K. N., X. Y. Yio, and C. A. Bona. 1994. Molecular characterization of J558 genes encoding tight skin mouse autoantibodies: identical heavy chain variable genes code for antibodies with different specificities. Proc. Natl. Acad. Sci. USA 91: 8067-8071.
38. Muryoi, T., J. Andre-Schwartz, Y. Saitoh, C. Daian, B. Hall, A. Dimitriu-Bona, R. S. Schwartz, C. A. Bona, and K. N. Kasturi. 1992. Self reactive repertorie of tight skin (TSK/+) mouse: immunochemical and molecular characterization of anti-cellular autoantibodies. Cell. Immunol. 144: 43-54.
39. Sawalha, A. H., and J. B. Harley. 2004. Antinuclear autoantibodies in systemic lupus erythematosus. Curr. Opin. Rheumatol. 16: 534-540.
40. Kavanaugh, A., R. Tomar, J. Reveille, D. H. Solomon, and H. A. Homburger. 2000. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch. Pathol. Lab. 124: 71-81.
41. Von Muhlen, C. A., and E. M. Tan. 1995. Autoantibodies in the diagnosis of systemic rheumatic diseases. Sem. Arthritis Rheum. 24: 323-358.
42. Peng, S. L., and J. Craft. 2005. Antinuclear antibodies, chapter 20. In Kelley's Textbook of Rheumatology, 7th Ed., Vol 1. E. D. Harris, R. C. Budd, G. S. Firestein, M. C. Genovese, J. S. Sergent, S. Ruddy, and C. B. Sledge, eds. Elsevier, Philadelphia.
43. Mitri, G. M., M. Lucas, N. Fertig, V. D. Steen, and T. A. Medsger, Jr. 2003. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum. 48: 203-209.
44. Parveen, S., S. A. Morshed, and M. Nishioka. 1995. High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities. J. Gastroenterol. Hepatol. 10: 438-445.
45. Conrad, K., G. Stahnke, B. Liedvogel, J. Mehlhom, J. Barth, C. Blasum, P. Altmeyer, N. Sonnichsen, and K. H. Frank. 1995. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma). J. Rheumatol. 221: 286-294.
46. Rahman, A. 2004. Autoantibodies, lupus and the science of sabotage. Rheumatology 43: 1326-1336.
47. Christner, P. J., L. D. Siracusa, D. F. Hawkins, R. McGrath, J. K. Betz, S. T. Ball, S. A. Jimenez, and J. A. Peters. 1996. High-resolution linkage map of the tight skin 2 locus: a mouse model for scleroderma (SSc) and other cutaneous fibrotic diseases. Mamm. Genome 7: 610-612.
48. Samarkos, M., and G. Vaiopoulos. 2005. The role of infections in the pathogenesis of autoimmune diseases. Curr. Drug Targets Inflamm. Allergy 4: 99-103.
49. Hamamdzic, D., L. Kasman, and E. LeRoy. 2002. Role of infectious agents in the pathogenesis of systemic sclerosis. Curr. Opin. Rheumatol. 14: 694-698.
50. Saito, E., M. Fujimoto, M. Hasegawa, K. Komura, Y. Hamaguchi, Y. Kaburagi, T. Nagaoka, K. Takehara, T. F. Tedder, and S. Sato. 2002. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight skin mouse. J. Clin. Invest. 109: 1453-1462.